- Form 8.5 (EPT/RI) - Renalytix plc
- Issue of Shares and Rule 2.9 Announcement
- Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
- Steno Diabetes Center (Copenhagen) Collaboration
- Holding(s) in Company
- Form 8.5 (EPT/RI) - Renalytix plc - Amendment
- Admission of the Second Tranche Placing Shares
- Nasdaq Delisting Determination - Appeal update
- Total Voting Rights
- Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
More ▼
Key statistics
As of last trade, Renalytix PLC (2O9A:MUN) traded at 0.29, 23.93% above the 52 week low of 0.234 set on Jul 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.29 |
---|---|
High | 0.29 |
Low | 0.29 |
Bid | 0.268 |
Offer | 0.288 |
Previous close | 0.29 |
Average volume | 33.33 |
---|---|
Shares outstanding | 82.96m |
Free float | 80.05m |
P/E (TTM) | -- |
Market cap | 28.91m USD |
EPS (TTM) | -0.7843 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 07:40 BST.
More ▼